Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Mirati Therapeutics (MRTX)

Mirati Therapeutics (MRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,565,409
  • Shares Outstanding, K 39,436
  • Annual Sales, $ 12,930 K
  • Annual Income, $ -98,420 K
  • 60-Month Beta 2.17
  • Price/Sales 515.43
  • Price/Cash Flow N/A
  • Price/Book 8.16

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -1.50
  • Number of Estimates 7
  • High Estimate -1.35
  • Low Estimate -1.71
  • Prior Year -0.87
  • Growth Rate Est. (year over year) -72.41%

Price Performance

See More
Period Period Low Period High Performance
1-Month
87.30 +0.19%
on 01/29/20
132.59 -34.03%
on 01/02/20
-40.96 (-31.89%)
since 12/27/19
3-Month
85.38 +2.45%
on 11/22/19
132.59 -34.03%
on 01/02/20
-7.63 (-8.02%)
since 10/29/19
52-Week
55.11 +58.72%
on 04/30/19
132.59 -34.03%
on 01/02/20
+25.32 (+40.74%)
since 01/29/19

Most Recent Stories

More News
Relatively Good Performance Detected in Shares of Mirati Therapeut in the Biotechnology Industry (MRTX, NVAX , XBIT , ALNY , STML )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

NVAX : 6.80 (-5.16%)
XBIT : 22.95 (-0.48%)
MRTX : 87.38 (-3.35%)
Mirati Therapeut Down 18.2% Since SmarTrend Downtrend Call (MRTX)

SmarTrend identified a Downtrend for Mirati Therapeut (NASDAQ:MRTX) on January 3rd, 2020 at $113.83. In approximately 3 weeks, Mirati Therapeut has returned 18.21% as of today's recent price of $93.10....

MRTX : 87.38 (-3.35%)
Mirati Therapeutics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares

Mirati Therapeutics, Inc. (Nasdaq: MRTX) today announced the closing of its previously announced underwritten public offering of 3,538,462 shares of its common stock at a public offering price of $97.50...

MRTX : 87.38 (-3.35%)
Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock

Mirati Therapeutics, Inc. (Nasdaq: MRTX) today announced the pricing of an underwritten public offering of 3,076,924 shares of its common stock at a price to the public of $97.50 per share. The aggregate...

MRTX : 87.38 (-3.35%)
Mirati Therapeutics Announces Proposed Public Offering of Common Stock

Mirati Therapeutics, Inc. (Nasdaq: MRTX) today announced that it intends to offer and sell, subject to market and other conditions, $250.0 million of shares of its common stock in an underwritten public...

MRTX : 87.38 (-3.35%)
Mirati Therapeutics Announces Executive Management Changes

Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology company, today announced changes to their executive management team, effective immediately. Mirati continues to accelerate the...

ONCE : 110.05 (-3.10%)
MRTX : 87.38 (-3.35%)
Mirati Therapeutics To Present At The 38th Annual J.P. Morgan Healthcare Conference

Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology company, will present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 13th at 4:00...

JPM : 134.59 (+0.12%)
MRTX : 87.38 (-3.35%)
Mirati Therapeut Up 26.0% Since SmarTrend Uptrend Call (MRTX)

SmarTrend identified an Uptrend for Mirati Therapeut (NASDAQ:MRTX) on November 27th, 2019 at $97.58. In approximately 4 weeks, Mirati Therapeut has returned 25.97% as of today's recent price of $122.92....

MRTX : 87.38 (-3.35%)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (MRTX, ACAD , NBIX , RGEN , SAGE )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

ACAD : 40.32 (-2.96%)
NBIX : 103.69 (+2.07%)
MRTX : 87.38 (-3.35%)
4 Drug/Biotech Outperformers That May Lose Steam in 2020

Here we discuss some biotech stocks, which are up this year so far but might not be good additions to your portfolio.

MRTX : 87.38 (-3.35%)
ANIP : 61.51 (+0.24%)
IMMU : 19.14 (+4.36%)
PTCT : 51.70 (+0.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Average short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade MRTX with:

Business Summary

Mirati Therapeutics, Inc. is a biopharmaceutical company. It engaged in the development of novel therapeutics for the treatment of cancer. Mirati Therapeutics, Inc., formerly known as MethylGene Inc., is based in Montreal, Canada.

See More

Key Turning Points

2nd Resistance Point 95.06
1st Resistance Point 92.74
Last Price 87.38
1st Support Level 88.08
2nd Support Level 85.74

See More

52-Week High 132.59
Fibonacci 61.8% 102.99
Fibonacci 50% 93.85
Last Price 87.38
Fibonacci 38.2% 84.71
52-Week Low 55.11

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar